期刊文献+

西达本胺对结肠癌细胞能量代谢的调节作用 被引量:4

Regulation of energy metabolism in colon cancer cells by chidamide
下载PDF
导出
摘要 目的考察西达本胺对结肠癌细胞HCT-8和HT-29能量代谢调节的作用。方法西达本胺5,10和20μmol·L^(-1)分别处理HCT-8和HT-29细胞,普通光学显微镜观察细胞形态变化,MTT法检测细胞存活,荧光细胞活性试剂盒检测ATP含量,糖酵解压力试剂盒检测代谢变化,荧光定量PCR和Western蛋白印迹法分别检测糖酵解关键酶乳酸脱氢酶A(LDH-A)在m RNA水平和蛋白水平的表达。结果与对照组相比,西达本胺处理组HCT-8和HT-29细胞形态不规则,出现变形、皱缩和细胞碎片,增殖抑制率显著升高(P<0.05);西达本胺5和10μmol·L^(-1)处理16 h,HCT-8和HT-29细胞内ATP总含量均无差异,而20μmol·L^(-1)处理组ATP总含量显著降低(P<0.05)。西达本胺20μmol·L^(-1)处理HCT-8和HT-29细胞16 h,有氧呼吸水平均无差异,而糖酵解ATP产生速率分别降低30.7%和37.9%(P<0.05);LDH-A m RNA水平无差异,蛋白水平显著下调(P<0.01)。结论西达本胺具有抑制结肠癌细胞糖酵解能力的作用,可能与下调LDH-A有关。 OBJECTIVE To observe the regulation effect of chidamide on energy metabolism in HCT-8 and HT-29 cells. METHODS HCT-8 and HT-29 cells were treated with chidamide 5,10 and20 μmol·L^- 1. Morphological changes of these cells were observed under an ordinary optical microscope.Cell proliferation was detected by MTT. ATP production was determined by Cell Titer-Glo assay kit.Metabolic changes were tested by glycolytic stress kit. The m RNA level of lactate dehydrogenase A(LDH-A)was analyzed by real-time quantitative PCR,whereas the protein level of LDH-A was analyzed by Western blotting. RESULTS Compared with control group,cell morphology of HCT-8 and HT-29 cells in chidamide treated group was irregular,accompanied by deformation,shrinkage and cell debris,and the inhibitory rate of proliferation increased(P〈0.05). There was no significant difference in ATP total content between chidamide 5 and 10 μmol·L^-116 h treatment groups,but in chidamide 20 μmol·L^-1treatment group it was decreased(P〈0.05). Chidamide 20 μmol·L^-1had no effect on oxygen consumption rate, but glycolysis ATP generation rate was reduced by 30.7% and 37.9%(P〈0.05),respectively.Chidamide 20 μmol·L^-1had no effect on LDH-A m RNA level,but it decreased the protein level of LDH-A(P〈0.01). CONCLUSION Chidamide can abate the respiratory metabolic ability of HCT-8and HT-29 cells. The mechanism may be related to the down-regulation of LDH-A.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2016年第5期539-544,共6页 Chinese Journal of Pharmacology and Toxicology
基金 北京市科技计划课题(Z141100000214003)~~
关键词 结肠癌细胞 西达本胺 乳酸脱氢酶A Warburg效应 colon cancer cells chidamide lactate dehydrogenase A Warburg effect
  • 相关文献

参考文献17

  • 1Wan-qing Chen,Hong-mei Zeng,Rong-shou Zheng,Si-wei Zhang,Jie He.Cancer Incidence and Mortality in China,2007[J].Chinese Journal of Cancer Research,2012,24(1):1-8. 被引量:94
  • 2Van Gijn W,Krijnen P,Lemmens VE,Den Dulk M,Putter H,Van De Velde CJ.Quality assurance in rectal cancer treatment in the Netherlands:a catch up compared to colon cancer treatment[J].Eur J Surg Oncol,2010,36(4):340-344.
  • 3Bolden JE,Peart MJ,Johnstone RW.Anticancer activities of histone deacetylase inhibitors[J].Nat Rev Drug Discov,2006,5(9):769-784.
  • 4Witt O,Deubzer HE,Milde T,Oehme I.HDAC family:what are the cancer relevant targets?[J].Cancer Lett,2009,277(1):8-21.
  • 5Dong M,Ning ZQ,Xing PY,Xu JL,Cao HX,Dou GF,et al.PhaseⅠstudy of chidamide(CS055/HBI-8000),a new histone deacetylase inhibitor,in patients with advanced solid tumors and lymphomas[J].Cancer Chemother Pharmacol,2012,69(6):1413-1422.
  • 6Koppenol WH,Bounds PL,Dang CV.Otto Warburg′s contributions to current concepts of cancer metabolism[J].Nat Rev Cancer,2011,11(5):325-337.
  • 7Dang CV,Hamaker M,Sun P,Le A,Gao P.Therapeutic targeting of cancer cell metabolism[J].J Mol Med(Berl,2011,89(3):205-212.
  • 8Cairns RA,Harris IS,Mak TW.Regulation of cancer cell metabolism[J].Nat Rev Cancer,2011,11(2):85-95.
  • 9Brahimi-Horn MC,Chiche J,Pouysségur J.Hypoxia signal ing controls metabolic demand[J].Curr Opin Cell Biol,2007,19(2):223-229.
  • 10Koukourakis MI,Giatromanolaki A,Harris AL,Sivridis E.Comparison of metabolic pathways between cancer cel s and stromal cel s in colorectal carcinomas:a metabolic survival role for tumorassociated stroma[J].Cancer Res,2006,66(2):632-637.

二级参考文献12

  • 1Ministry of Health. National death survey report,2004-2005[M].Beijing:Peking Union Medical College Publication House,2008.
  • 2Lu FZ,Zhang SW,Chen YH. Investigation analysis of cancer registration in China[J].Zhong Guo Zhong Liu,2004.134-41.
  • 3Chen WQ,Zhao P,Rao KQ. A primary cancer registration system in China,2010[J].Zhonghua Yufang Yixue Zazhi,2010.374-5.
  • 4National Office for Cancer Prevention and Control.China cancer annual report,2010[M]北京:军事医学科学出版社,2011.
  • 5Curado MP,Edwards B,Shin HR. Cancer Incidence in Five Continents,Vol.Ⅸ[A].Lyon:iarc Press,2007.
  • 6Parkin DM,Chen VW,Ferlay J. Comparability and quality control in cancer registration.[=IARC Technical Report No.19,][R].Lyon:iarc Press,1994.
  • 7Felay J,Burkhard C,Whelan S. Check and conversion programs for cancer registries.[IARC Technical Report No.42.][R].Lyon:iarc Press,2005.
  • 8Chen WQ,Zhang SW,Zou XN. Cancer incidence and mortality in China,2006[J].Chinese Journal of Cancer Research,2011.3-9.
  • 9Chen WQ,Zheng RS,Zeng HM. Bayesian age-period-cohort prediction of lung cancer incidence in China[J].Thoracic Cancer,2011.149-55.
  • 10Shopland DR,Eyre H J,Pechacek TF. Smoking-attributable cancer mortality in,1991:is lung cancer now the leading cause of death among smokers in the United States[J].Journal of the National Cancer Institute,1991.1142-8.

共引文献93

同被引文献27

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部